Health Services Laboratories unlocks faster turnaround times for NHS pathology services by collaborating with Automata

As of summer 2023, Health Services Laboratories, an innovation-led provider of pathology and diagnostic services, and Automata Technologies, a life-sciences automation company, have partnered to speed up turnaround times for pathology and diagnostic services.

Lexicon resubmits type 1 diabetes drug to FDA five years after rejection

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 22, 2024

Payers generally meet drug price watchdog’s ‘fair access’ standards, report says

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 20, 2024

Novo Holdings acquires biopharma company Paratek for $462m

Paratek is currently carrying out a Phase IIb clinical trial of Nuzyra for nontuberculous mycobacterial pulmonary disease. Credit: fizkes/Shutterstock.com. Novo Holdings has concluded the acquisition of

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.